Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation, Graft-Versus-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00454155
What this trial is testing

Study of Opebacan in Patients Undergoing Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Graft Versus Host Disease
XOMA (US) LLC 6
Testing effectiveness (Phase 2)Study completedNCT00153985
What this trial is testing

Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies

Who this might be right for
HemoglobinopathiesSickle Cell DiseaseThalassemia
Dana-Farber Cancer Institute 2
Early research (Phase 1)Looking for participantsNCT03533816
What this trial is testing

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

Who this might be right for
Acute Myeloid LeukemiaChronic Myeloid LeukemiaAcute Lymphoblastic Leukemia+1 more
University of Kansas Medical Center 38
Not applicableStudy completedNCT03072849
What this trial is testing

Early Detection and Management of Bronchiolitis Obliterans Syndrome Following Pediatric Hematopoietic Stem Cell Transplantation

Who this might be right for
Bronchiolitis Obliterans Syndrome
Ann & Robert H Lurie Children's Hospital of Chicago 23
Testing effectiveness (Phase 2)Looking for participantsNCT05531786
What this trial is testing

Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Graft vs Host Disease
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT01860170
What this trial is testing

Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis

Who this might be right for
Hematological Malignancy
Corewell Health West 28
Testing effectiveness (Phase 2)Study completedNCT02663622
What this trial is testing

Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002)

Who this might be right for
Graft Versus Host DiseaseHematopoietic Stem Cell TransplantationLeukemia
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 44
Large-scale testing (Phase 3)UnknownNCT00934557
What this trial is testing

Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell Transplantation

Who this might be right for
Paediatric Patients Affected by Haematological Malignancies and Eligible to Undergo HSCT From an Unrelated Volunteer
Fondazione IRCCS Policlinico San Matteo di Pavia 42
Testing effectiveness (Phase 2)Study completedNCT02799147
What this trial is testing

GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia

Who this might be right for
Leukemia, Acute LymphoblasticAcute Myeloid LeukemiaMixed-Lineage Acute Leukemias
St. Petersburg State Pavlov Medical University 27
Testing effectiveness (Phase 2)Study completedNCT00577278
What this trial is testing

A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma
City of Hope Medical Center 41
Large-scale testing (Phase 3)Study completedNCT00655343
What this trial is testing

Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT)

Who this might be right for
Graft vs Host Disease
Neovii Biotech 202
Testing effectiveness (Phase 2)Study completedNCT00003661
What this trial is testing

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Roswell Park Cancer Institute 3
Large-scale testing (Phase 3)Ended earlyNCT02411084
What this trial is testing

Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD

Who this might be right for
Graft vs Host Disease
Adienne SA 36
Early research (Phase 1)Study completedNCT03755414
What this trial is testing

Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaMyelodysplastic Syndromes+2 more
Washington University School of Medicine 55
Very early researchStudy completedNCT04628338
What this trial is testing

IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Myelodysplastic SyndromesMyeloid LeukemiaAllogeneic Stem Cell Transplantation
Sawa Ito, MD 8
Large-scale testing (Phase 3)Ended earlyNCT04095858
What this trial is testing

Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005)

Who this might be right for
Hematopoietic Stem Cell TransplantationAcute Graft Versus Host DiseaseAcute Myeloid Leukemia+2 more
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 11
Testing effectiveness (Phase 2)Study completedNCT00061581
What this trial is testing

Experimental Bone Marrow Transplant Protocol

Who this might be right for
Acute Lymphocytic LeukemiaChronic Myeloid LeukemiaAcute Myelocytic Leukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 14
Testing effectiveness (Phase 2)Looking for participantsNCT05675930
What this trial is testing

Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant

Who this might be right for
Graft-Versus-Host DiseaseGVHDUndefined
Memorial Sloan Kettering Cancer Center 44
Testing effectiveness (Phase 2)Ended earlyNCT04200365
What this trial is testing

Itacitinib for the Treatment of Chronic Graft Versus Host Disease (cGVHD)

Who this might be right for
Chronic Graft-versus-host-disease
SCRI Development Innovations, LLC 15
Early research (Phase 1)Ended earlyNCT01950507
What this trial is testing

Evaluation of Budesonide and How It Interacts With Antifungal Drugs in People With Gastrointestinal Graft-Versus-Host Disease

Who this might be right for
Stem Cell TransplantationGraft vs Host Disease
National Institutes of Health Clinical Center (CC) 15
Next Page